Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJ NYSE:JPM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$188.98+0.0%$177.04$140.68▼$189.92$454.83B0.48.89 million shs4,575 shsJPMJPMorgan Chase & Co.$304.97-0.9%$301.10$202.16▼$318.01$840.76B1.139.52 million shs11,823 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+0.38%+1.91%+6.04%+21.07%+18.42%JPMJPMorgan Chase & Co.-0.50%-2.51%+4.35%+8.72%+45.85%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$188.98+0.0%$177.04$140.68▼$189.92$454.83B0.48.89 million shs4,575 shsJPMJPMorgan Chase & Co.$304.97-0.9%$301.10$202.16▼$318.01$840.76B1.139.52 million shs11,823 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+0.38%+1.91%+6.04%+21.07%+18.42%JPMJPMorgan Chase & Co.-0.50%-2.51%+4.35%+8.72%+45.85%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.68Moderate Buy$189.880.48% UpsideJPMJPMorgan Chase & Co. 2.46Hold$309.951.63% UpsideCurrent Analyst Ratings BreakdownLatest JNJ and JPM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/7/2025JNJJohnson & JohnsonCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$200.00 ➝ $213.0010/7/2025JPMJPMorgan Chase & Co.UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$339.00 ➝ $350.0010/6/2025JNJJohnson & JohnsonSanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Perform$172.00 ➝ $193.0010/3/2025JNJJohnson & JohnsonUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$198.0010/3/2025JNJJohnson & JohnsonWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetEqual Weight ➝ Overweight$170.00 ➝ $212.0010/3/2025JNJJohnson & JohnsonWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$170.00 ➝ $212.0010/3/2025JNJJohnson & JohnsonBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$175.00 ➝ $198.0010/3/2025JPMJPMorgan Chase & Co.The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$336.00 ➝ $350.0010/3/2025JPMJPMorgan Chase & Co.TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$350.00 ➝ $370.009/30/2025JPMJPMorgan Chase & Co.Evercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$309.00 ➝ $330.009/30/2025JPMJPMorgan Chase & Co.The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$330.00(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$88.82B5.12$13.18 per share14.34$29.69 per share6.36JPMJPMorgan Chase & Co.$278.91B3.01$21.72 per share14.04$115.33 per share2.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$9.3520.2017.072.4025.00%32.49%13.00%10/14/2025 (Estimated)JPMJPMorgan Chase & Co.$58.47B$19.4915.6915.702.0320.52%16.93%1.30%10/14/2025 (Estimated)Latest JNJ and JPM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/14/2025Q3 2025JNJJohnson & Johnson$2.78N/AN/AN/A$23.73 billionN/A10/14/2025Q3 2025JPMJPMorgan Chase & Co.$4.72N/AN/AN/A$44.42 billionN/A7/16/2025Q2 2025JNJJohnson & Johnson$2.68$2.77+$0.09$2.29$22.85 billion$23.74 billion7/15/2025Q2 2025JPMJPMorgan Chase & Co.$4.48$4.96+$0.48$5.24$43.76 billion$44.91 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.202.75%N/A55.61%64 YearsJPMJPMorgan Chase & Co.$6.001.97%N/A30.79%15 YearsLatest JNJ and JPM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/16/2025JPMJPMorgan Chase & Co.quarterly$1.501.94%10/6/202510/6/202510/31/20257/16/2025JNJJohnson & Johnsonquarterly$1.303.35%8/26/20258/26/20259/9/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.501.010.76JPMJPMorgan Chase & Co.1.250.880.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%JPMJPMorgan Chase & Co.71.55%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%JPMJPMorgan Chase & Co.0.47%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,1002.41 billion2.40 billionOptionableJPMJPMorgan Chase & Co.317,2332.75 billion2.74 billionOptionableJNJ and JPM HeadlinesRecent News About These CompaniesJPMorgan's Jamie Dimon Says AI Is Going to Eliminate Some Jobs1 hour ago | youtube.comYJPMorgan Says Stablecoins Could Add $1.4 Trillion in Dollar Demand by 20271 hour ago | tipranks.comJPMorgan Q3 Earnings Preview: Time To Find Out The Pulse Of The Consumer2 hours ago | seekingalpha.comWhat is Seaport Res Ptn's Estimate for JPM Q1 Earnings?3 hours ago | marketbeat.comStablecoins may drum up $1.4 trillion of extra dollar demand by 2027, JPM says3 hours ago | finance.yahoo.comJPMorgan Downgrades FedEx Stock (FDX) to Hold on Freight Business Challenges5 hours ago | tipranks.comJamie Dimon says JPMorgan's $2 billion AI investment is already paying off5 hours ago | businessinsider.comPure Financial Advisors LLC Raises Position in JPMorgan Chase & Co. $JPMOctober 8 at 3:39 AM | marketbeat.comRobeco Institutional Asset Management B.V. Has $1.07 Billion Stake in JPMorgan Chase & Co. $JPMOctober 8 at 3:39 AM | marketbeat.comJPMorgan Chase & Co. $JPM Holdings Lowered by Clarity Financial LLCOctober 8 at 3:39 AM | marketbeat.comWoodward Diversified Capital LLC Has $3.41 Million Position in JPMorgan Chase & Co. $JPMOctober 8 at 3:38 AM | marketbeat.comBOCHK Asset Management Ltd Has $870,000 Stake in JPMorgan Chase & Co. $JPMOctober 8 at 3:38 AM | marketbeat.comHudson Value Partners LLC Grows Stock Position in JPMorgan Chase & Co. $JPMOctober 8 at 3:38 AM | marketbeat.com1,348 Shares in JPMorgan Chase & Co. $JPM Acquired by Precision Wealth Strategies LLCOctober 8 at 3:38 AM | marketbeat.comNewman Dignan & Sheerar Inc. Has $5.91 Million Stock Position in JPMorgan Chase & Co. $JPMOctober 8 at 3:38 AM | marketbeat.comVigilare Wealth Management Raises Stake in JPMorgan Chase & Co. $JPMOctober 8 at 3:38 AM | marketbeat.comQTR Family Wealth LLC Increases Position in JPMorgan Chase & Co. $JPMOctober 8 at 3:28 AM | marketbeat.comNinety One SA PTY Ltd Lowers Stake in JPMorgan Chase & Co. $JPMOctober 8 at 3:28 AM | marketbeat.comJPMorgan Chase & Co. $JPM Shares Acquired by First Pacific FinancialOctober 8 at 3:28 AM | marketbeat.comJPMorganChase Announces Major Investments in its Bournemouth Campus and the CommunityOctober 8 at 3:00 AM | businesswire.comJPMorgan Chase's Peter Scher, a key D.C-area executive, to retire after 18 yearsOctober 8 at 2:59 AM | bizjournals.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025Why AbbVie and Johnson & Johnson Could Outperform PfizerBy Chris Markoch | October 8, 2025JNJ and JPM Company DescriptionsJohnson & Johnson NYSE:JNJ$188.98 +0.09 (+0.04%) As of 09:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.JPMorgan Chase & Co. NYSE:JPM$304.97 -2.72 (-0.89%) As of 09:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector 3 Dividend Aristocrats to Buy Before Year’s End The Juice Is Loose: Why Plug Power's Rally Is Just the Beginning Joby's Stock Rallies as Public Flights Validate Global Game Plan SharkNinja Is Flashing a Buy Signal the Market Is Ignoring Why Semtech Stock Is Rallying After Its NVIDIA Setback Marvell Insiders Buy Shares—Should Investors Follow Suit? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
